Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Magdalena Dryglewska"'
Publikováno v:
Annals of Agricultural and Environmental Medicine, Vol 28, Iss 1, Pp 189-192 (2021)
Introduction Anti-PM/Scl (a-PM/Scl) antibodies are found in different systemic autoimmune diseases such as polymyositis, dermatomyositis, systemic sclerosis (SSc) and overlap syndromes. According to literature, they are detected in approx. 2% of SSc
Externí odkaz:
https://doaj.org/article/d802a40f0268473586b8bbaf8e36d967
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Background: Anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are key factors in the American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis (RA) classification criteria markers. However, about
Externí odkaz:
https://doaj.org/article/686194c42f894fa8acc5d58b0a7cf054
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0233897 (2020)
OBJECTIVES:miR-155 plays a critical role in the inflammatory process and in diseases such as rheumatoid arthritis (RA). miR155 gene expression is regulated by its gene promoter region CpG island methylation. Previous studies have shown inconsistent c
Externí odkaz:
https://doaj.org/article/8ffd210451284999873d8b3ca11921f6
Publikováno v:
Central European Journal of Immunology, Vol 42, Iss 2, Pp 161-166 (2017)
Aim of the study: The aim of the study was the assessment of changes in the glomerular filtration rate (GFR) during long-term observation in a group of systemic sclerosis (SSc) patients with and without chronic antiphospholipid (aPL) antibody positiv
Externí odkaz:
https://doaj.org/article/7df8d3b9fade46279c1e7ee9f9ce8bd6
Publikováno v:
Rheumatology, Vol 53, Iss 6, Pp 315-320 (2016)
Objectives : The course of systemic sclerosis (SSc) can differ in female and male patients. According to the literature the incidence rates of diffuse cutaneous SSc, scleroderma renal crisis and digital ulceration are higher in male patients. The aim
Externí odkaz:
https://doaj.org/article/fe45a6bf4b50414bafdcec29834be79b
Publikováno v:
Rheumatology, Vol 53, Iss 2, Pp 61-68 (2015)
Objectives : The aim of the study was to investigate the prevalence of selected organ-specific autoantibodies in rheumatoid arthritis (RA) and primary Sjögren’s syndrome (pSS) patients, and discuss their clinical significance. Material and methods
Externí odkaz:
https://doaj.org/article/1558babebe4f49c3916aaca76d076030
Publikováno v:
Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii
Advances in Dermatology and Allergology, Vol 37, Iss 6, Pp 909-914 (2021)
Advances in Dermatology and Allergology, Vol 37, Iss 6, Pp 909-914 (2021)
Introduction Anti-RNA polymerase III (a-RNA Pol III) antibodies are marker antibodies in patients with systemic sclerosis (SSc). Aim To assess the prevalence of a-RNA Pol III in patients with SSc and to identify the differences in the disease picture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b32f51eef7a22a5fb01bd4820ce502
http://europepmc.org/articles/PMC7874867
http://europepmc.org/articles/PMC7874867
Publikováno v:
Postepy dermatologii i alergologii. 39(5)
Arterial hypertension (AH) is common in systemic connective tissue diseases.To evaluate the incidence of AH in patients with systemic sclerosis (SSc) and to present clinical characteristics of the group diagnosed with AH.The study involved 108 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed6e92b25e087e79d0f8c23016fe45d1
https://pubmed.ncbi.nlm.nih.gov/36457666
https://pubmed.ncbi.nlm.nih.gov/36457666
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Background: Anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are key factors in the American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis (RA) classification criteria markers. However, about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3e3a9be4f07be2a18ffc8ef6ab18ae
http://europepmc.org/articles/PMC7882754
http://europepmc.org/articles/PMC7882754
Publikováno v:
Abstracts Accepted for Publication.
Background Antiphospholipid syndrome (APS) could be diagnosed as primary (PAPS) or secondary (SAPS - accompanying other diseases, mainly found in patients with systemic lupus erythematosus -SLE) Objectives The aim of our study was to determine if pts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::145e6944a07695abe33e4aaf3ad732bb
https://doi.org/10.1136/annrheumdis-2019-eular.1944
https://doi.org/10.1136/annrheumdis-2019-eular.1944